Mr Joris Komen

Institute for Pharmaceutical Sciences, Utrecht (Netherlands (The))

Follow

Contributor content

Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience

Presentation

Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience